A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients
Clinical trial NCT03419975 · COMPLETED
Trial details
- NCT number
- NCT03419975
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-26
- Primary completion
- 2017-12-28
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.